Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants
Maria Iacobescu(Iuliu Hațieganu University of Medicine and Pharmacy), Dan Tătaru(Iuliu Hațieganu University of Medicine and Pharmacy), Cristina Pop(Iuliu Hațieganu University of Medicine and Pharmacy), Jón Þór Bergþorsson(deCODE Genetics (Iceland)), Alina Uifălean(Iuliu Hațieganu University of Medicine and Pharmacy), Cristina Mogoșan(Iuliu Hațieganu University of Medicine and Pharmacy), Mihnea Zdrenghea(Iuliu Hațieganu University of Medicine and Pharmacy), Mihai Cenariu(University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca), Alina Tănase(Institutul Clinic Fundeni), Ciprian Tomuleasa(Iuliu Hațieganu University of Medicine and Pharmacy), Diana Cenariu(Iuliu Hațieganu University of Medicine and Pharmacy), Victor Greiff(Oslo University Hospital), Cristina Adela Iuga(Iuliu Hațieganu University of Medicine and Pharmacy)
Cited by 5
Related Papers
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
|Nature Genetics|2007|725
Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis
|Hepatology|2014|224
Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrow
|Nature Communications|2020|205
Linking genes of unknown function with abiotic stress responses by high‐throughput phenotype screening
|Physiologia Plantarum|2013|130
Diversity in immunogenomics: the value and the challenge
|Nature Methods|2021|79